Position
Chief Executive Officer
Company
Silence Therapeutics plc
LondonBiotechnologyHealth CareTherapeuticsDescription
Silence Therapeutics announced that Craig Tooman has left his position as President and Chief Executive Officer effective December 14, 2025. Iain Ross will take over leadership on an interim basis.
Quick answer
Silence Therapeutics Appoints Iain Ross as Interim Chief Executive Officer (December 15, 2025). Silence Therapeutics plc is based in London, England, United Kingdom.
- Who is the new Chief Executive Officer at Silence Therapeutics plc?
- Silence Therapeutics plc named Iain Ross Chief Executive Officer, announced December 15, 2025.
- What did Silence Therapeutics plc announce on December 15, 2025?
- Silence Therapeutics announced that Craig Tooman has left his position as President and Chief Executive Officer effective December 14, 2025. Iain Ross will take over leadership on an interim basis.
- What does Silence Therapeutics plc do?
- Silence Therapeutics is a global clinical-stage biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines created with proprietary siRNA technology.
- Where is Silence Therapeutics plc based?
- Silence Therapeutics plc is based in London, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Pliant Therapeutics (December 16, 2025), Topadur Pharma AG (December 17, 2025), Centessa Pharmaceuticals plc (December 12, 2025) and Gilead Sciences (December 18, 2025) also announced leadership changes within 45 days of Silence Therapeutics plc.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pliant Therapeutics Appoints Minnie Kuo as Chief Operating Officer (December 16, 2025)
- Topadur Pharma AG Appoints Matthias Schäfer as Chief Executive Officer (December 17, 2025)
- Centessa Pharmaceuticals Appoints Mario Alberto Accardi as CEO (December 12, 2025)
- Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel (December 18, 2025)
- Enliven Appoints Rick Fair as Chief Executive Officer (December 11, 2025)
- Expression Therapeutics Appoints David F. Townson as Chief Executive Officer (December 10, 2025)
Who to call at Silence Therapeutics plc, and when
A new leader at Silence Therapeutics plc brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Silence Therapeutics plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Silence Therapeutics plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Silence Therapeutics plc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Silence Therapeutics plc changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Silence Therapeutics plc changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.